Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page
- ChecktodayChange DetectedA notice was added announcing NIH website updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition. It appears above the study record, which remains inaccessible.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1; the 403 error page otherwise remains unchanged.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study content and navigation. This makes the study record inaccessible until the error is resolved.SummaryDifference17%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a small metadata update to the study record. It does not alter the study details or participant-related information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe Study Documents section now includes downloadable PDFs for the Study Protocol and SAP, with metadata such as dates and file sizes. This expands access to key trial documentation and clarifies the study’s design and analysis approach.SummaryDifference100%

Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.